Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Plaintiffs Accept Draft Bill To Settle Hepatitis C Suits (Japan)

This article was originally published in PharmAsia News

Executive Summary

Plaintiffs suing the Japanese government and makers of tainted blood products accepted the terms of a draft bill to provide blanket relief to relatives or patients who contracted hepatitis C. The party coalition that rules Japan's Diet drafted the legislation at the urging of the prime minister, and plaintiff acceptance is seen as improving chances for settlement of the suits. Among the draft's provisions is one requiring drug makers of the products to contribute to a $179 billion fund in the Pharmaceuticals and Medical Devices Agency to cover benefits and other payments to patients whose conditions continue to worsen. The proposal is to be presented to the Diet Jan. 7. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066755

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel